Hi folks, I’m accepting a clinical psych doctoral student for Fall 2024 at CU Boulder. First-gen and underrepresented-identity folks strongly encouraged to apply! Areas of research: trauma, sexualized and gender-based violence, sexuality, and identity.
Ever wondered how many symptoms make up all of adult psychopathology described in the DSM-5? It’s 628!
How many do you think repeat across multiple diagnoses? If you answered 231 symptoms repeating a total of 1022 times (median 3 times per symptom, range 2-22), good job!
🧵
Congratulations @junegruber, @ElisaStern3, Amelia Moser, and Kourtney Kelley on your truly FANTASTIC presentations at last night's “Coloradan Conversations” event. We are proud to have such incredible scientists @CUBoulder!
Congratulations to Clinical PhD student @SteviIbonie (mentored by @junegruber) for receiving a Beverly Sears Research Grant! These extremely competitive awards support the research, scholarship, and creative work of graduate students from across @CUBoulder. Congratulations Stevi!
Interested in genetic risk-factors leading to deviations in structural connectome development and psychopathology in adolescence🧠📈?
Check our latest in AmericanJournalPsychiatry @APAPubJournals w/ Gloria Roberts (co-lead), Phil Mitchell & @DrBreaky https://t.co/JX0fK1QBn3 /1
@corina_rz i've also heard t2t is basically impossible to get around at this point :/ it's definitely expensive, but if you can swing purchasing 4 years up front it cuts down on costs drastically in the long run
Thrilled that our review of neuroimaging studies on adolescent cannabis use is out! In addition to reviewing/synthesizing existing studies, we provide recommendations for future research in this area to begin to bridge current gaps in the literature: https://t.co/U57CKYMVo9
We're incredibly excited to announce the upcoming launch of @PsychgeistMedia, coming in early 2022! Psychgeist is a nonprofit dedicated to helping behavioral scientists share their research with the public in an engaging and responsible way. https://t.co/LwswLkinUU
Two #YalePsych researchers have been awarded a $2 million grant from @MichaelJFoxOrg for Parkinson’s Research to conduct the first clinical trial of ketamine to treat depression in people with Parkinson’s disease. Read more: https://t.co/3btCJEg0Hh @YaleMed@sophie_eholmes
Just accepted to @npp_journal - Systematic Review of Structural and Functional Neuroimaging Studies of Cannabis Use in Adolescence and Emerging Adulthood: Evidence from 90 studies and 9,441 participants
Congrats to @lichsar for putting together this monumental effort!!